(Q57715646)

5

0 references

Tadej Battelino

object named as

Tadej Battelino

6

0 references

author name string

Urh Groselj

1

0 references

Mojca Zerjav Tansek

2

0 references

Jernej Kovac

3

0 references

Tinka Hovnik

Molecular Genetics and Metabolism

4

0 references

publication date

June 2012

0 references

published in

0 references

volume

106

0 references

issue

2

0 references

page(s)

142-148

0 references

cites work

Follow-up study of 16 years neonatal screening for inborn errors of metabolism in West Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

There is no doubt that the early identification of PKU and prompt and continuous intervention prevents mental retardation in most patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

PAHdb 2003: what a locus-specific knowledgebase can do.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

A single origin of phenylketonuria in Yemenite Jews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Exon deletions of the phenylalanine hydroxylase gene in Italian hyperphenylalaninemics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Identification and characterization of large deletions in the phenylalanine hydroxylase (PAH) gene by MLPA: evidence for both homologous and non-homologous mechanisms of rearrangement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Phenylketonuria mutations in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Monogenic traits are not simple: lessons from phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Modifier genes convert "simple" Mendelian disorders to complex traits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Low proportion of whole exon deletions causing phenylketonuria in Denmark and Germany.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

The molecular basis of phenylalanine hydroxylase deficiency in Croatia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Molecular and phenotypic characteristics of patients with phenylketonuria in Serbia and Montenegro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Molecular Epidemiology of Phenylalanine Hydroxylase Deficiency in Southern Italy: a 96% Detection Rate with Ten Novel Mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Should newborn mutation scanning for hyperphenylalaninaemia and galactosaemia be implemented? A Polish experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Single exon deletions in the PAH gene in Polish PKU-patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Significance of genotype in tetrahydrobiopterin-responsive phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015

Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.03.015